Network model of survival signaling in large granular lymphocyte leukemia.
about
Mathematical biology modules based on modern molecular biology and modern discrete mathematicsLogical Modeling and Dynamical Analysis of Cellular NetworksLarge granular lymphocytosis during dasatinib therapySystems biology approaches for advancing the discovery of effective drug combinationsSomatic STAT3 mutations in large granular lymphocytic leukemiaON/OFF and beyond--a boolean model of apoptosisMathematical modelling of cell-fate decision in response to death receptor engagementTraining signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuliDiscovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical ModelingSphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.Inference of Network Dynamics and Metabolic Interactions in the Gut MicrobiomeThe pathogenesis and treatment of large granular lymphocyte leukemiaRealistic control of network dynamics.Boolean network simulations for life scientists.Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.Identification of a topological characteristic responsible for the biological robustness of regulatory networksCorrelations in the degeneracy of structurally controllable topologies for networks.Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.Toward the dynamic interactome: it's about time.Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction.Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.Elementary signaling modes predict the essentiality of signal transduction network components.Sphingosine kinase 1 in cancer.Simulating quantitative cellular responses using asynchronous threshold Boolean network ensembles.Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia.Network model of immune responses reveals key effectors to single and co-infection dynamics by a respiratory bacterium and a gastrointestinal helminth.NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.Nonparametric simulation of signal transduction networks with semi-synchronized updateUnderstanding disease mechanisms with models of signaling pathway activities.Multi-level modeling of light-induced stomatal opening offers new insights into its regulation by drought.NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networksDetection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.How I treat LGL leukemia.Dynamics of DNA damage induced pathways to cancerStabilization of perturbed Boolean network attractors through compensatory interactions.Steady state analysis of Boolean molecular network models via model reduction and computational algebra.Cell fate reprogramming by control of intracellular network dynamics.
P2860
Q24620142-EC22FC27-85E9-4862-A5D4-5643865BB8C6Q26745955-DC857C04-1182-41AE-800A-E4BBAF8BA8ECQ27012699-9A35301D-313A-4753-9CAF-2EB00862FB51Q27702922-31752326-E6E0-4F0A-BF67-CCF87D4A3FA6Q27851792-D0AD4EEE-2103-4E5D-856C-A82F58FAF02FQ28472140-F6DCE38C-BF56-4FF3-BA4D-A256562368F8Q28473094-84288EBD-CDD0-444E-AC3F-C968A8882D4CQ28477321-0B9A38FE-25F2-43A2-A1A5-38DF50C79F9DQ28547862-3CCC063F-E5E6-421E-82CC-FF508014C957Q30278883-7F01AC15-F6A8-4305-8F35-6C27BC595377Q30303110-34D57FB0-2D08-4FAB-83B4-BF4AE5FA2B38Q30303161-21C5FB8A-A36A-420C-B8D9-ACC7500F547FQ30384334-8A38F743-D65A-4470-9B83-3C63907F5707Q30405429-FE9A4D70-ADC0-4C02-B612-1891AC901B2BQ30574112-07FA8F5B-2F79-472A-BE7A-D2D29437E1F2Q33384933-F3475DE4-A568-4D9A-BC54-B65D3B98C667Q33402525-6F694BAD-E0A2-4244-AFC5-A2D298108208Q33486465-6AF0EAAD-6EA4-40F1-93A5-A23728FEBBCEQ33555470-CD117DAE-59B4-4339-9241-81E2B2629A2BQ33579520-D50DCF05-504B-4CD4-BA95-52F6DDD7DB14Q33605065-17B90F31-748C-487B-ABA3-EB022DB1D946Q33668279-0FB2A60E-BE05-4FA2-A259-3074C7576419Q33680566-A5E81AC1-56F4-4F9A-8357-979ADD7CF581Q33852639-E0C94572-D427-4EDA-9CF5-3E08BF6E1AE0Q33853998-8A14DAA8-9FB7-42C5-AD89-301AAA284492Q33957286-3937632F-A7BD-44C9-A670-CBF6491F9CBAQ34079139-2FE0FC7D-86F0-47AC-8DA2-093B3D349E59Q34130164-D8997CDE-2CC9-4F53-90FB-85217CEC67CFQ34167778-F06DE060-D886-4088-9F0A-8B749DC5B63AQ34282342-5C95F761-DDA8-4405-866E-A1F4095C8315Q34318470-14A79CF0-10F5-4A99-84BD-0602253D694BQ34422921-F511D0F3-5FD1-4877-9677-89FDE6884AB0Q34504840-BE1AF6BD-6703-42B9-B5F9-CD584F8FFC64Q34535954-564DE50C-6D1E-45F4-BE72-1C0CA98E46A4Q34649095-15F8B7EA-16F1-45EA-99A5-7A319D50C001Q34707130-3D3D07C8-C7F0-4F1F-9AE1-6EC84DAAE5E9Q34983908-44B52191-E4DB-48CF-BAB6-E8EABDD5120CQ35178902-3DCC0ED2-04B8-4036-9274-D373A1F233FCQ35194958-7096A1DA-BDB6-49C0-AB74-CEDD2C06C991Q35596638-A40127FC-4816-4A8F-BB10-685F29973327
P2860
Network model of survival signaling in large granular lymphocyte leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Network model of survival signaling in large granular lymphocyte leukemia.
@en
type
label
Network model of survival signaling in large granular lymphocyte leukemia.
@en
prefLabel
Network model of survival signaling in large granular lymphocyte leukemia.
@en
P2093
P2860
P356
P1476
Network model of survival signaling in large granular lymphocyte leukemia.
@en
P2093
Jong K Yun
Mithun Vinod Shah
Ranran Zhang
Réka Albert
Susan B Nyland
Thomas P Loughran
P2860
P304
16308-16313
P356
10.1073/PNAS.0806447105
P407
P577
2008-10-13T00:00:00Z